These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe. Teschke R; Glass X; Schulze J; Eickhoff A Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):270-80. PubMed ID: 22189691 [TBL] [Abstract][Full Text] [Related]
3. Greater Celandine hepatotoxicity: a clinical review. Teschke R; Frenzel C; Glass X; Schulze J; Eickhoff A Ann Hepatol; 2012; 11(6):838-48. PubMed ID: 23109446 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality? Teschke R; Schmidt-Taenzer W; Wolff A Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069 [TBL] [Abstract][Full Text] [Related]
5. Kava hepatotoxicity: regulatory data selection and causality assessment. Teschke R; Wolff A Dig Liver Dis; 2009 Dec; 41(12):891-901. PubMed ID: 19477698 [TBL] [Abstract][Full Text] [Related]
6. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679 [TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity induced by greater celandine (Chelidonium majus L.): a review of the literature. Pantano F; Mannocchi G; Marinelli E; Gentili S; Graziano S; Busardò FP; di Luca NM Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):46-52. PubMed ID: 28379595 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case. Moro PA; Cassetti F; Giugliano G; Falce MT; Mazzanti G; Menniti-Ippolito F; Raschetti R; Santuccio C J Ethnopharmacol; 2009 Jul; 124(2):328-32. PubMed ID: 19397968 [TBL] [Abstract][Full Text] [Related]
9. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. Teschke R; Frenzel C; Wolff A; Herzog J; Glass X; Schulze J; Eickhoff A Ann Hepatol; 2012; 11(4):500-12. PubMed ID: 22700632 [TBL] [Abstract][Full Text] [Related]
10. A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L. : Report of Two Cases of Herb-Induced Liver Injury and Literature Review. Ciornolutchii V; Ismaiel A; Sabo CM; Al Hajjar N; Seicean A; Dumitrascu DL Am J Ther; 2024 Jul-Aug 01; 31(4):e382-e387. PubMed ID: 38820341 [TBL] [Abstract][Full Text] [Related]
11. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. Teschke R; Frenzel C; Schulze J; Eickhoff A World J Gastroenterol; 2013 May; 19(19):2864-82. PubMed ID: 23704820 [TBL] [Abstract][Full Text] [Related]
12. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Teschke R; Wolff A Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions]. Teschke R; Schulze J Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353 [TBL] [Abstract][Full Text] [Related]
20. [Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus)]. Crijns AP; de Smet PA; van den Heuvel M; Schot BW; Haagsma EB Ned Tijdschr Geneeskd; 2002 Jan; 146(3):124-8. PubMed ID: 11826672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]